Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3 clinical trial of Axumin (fluciclovine F 18) injection. Axumin is a novel molecular imaging agent indicated for use in positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated blood levels of prostate-specific antigen (PSA) following prior treatment. Results of the multi-center study, conducted in Norway, Italy and the United States, demonstrated a 68 percent overall detection rate (DR) for Axumin, with the ability to detect local, as well as distant, prostate cancer recurrence across a wide range of PSA values. Axumin was well-tolerated in the study.
A recent study published in the American Journal of Roentgenology shows that early signs of breast cancer can be more easily detected when comparisons to prior mammograms are available. Comparing a current scan with a prior study enables radiologists to identify important changes that can indicate an irregularity, since what is normal varies on a patient-by-patient basis.
Leadership from the American Society for Radiation Oncology (ASTRO) recently participated in an event at the White House hosted by Vice President Joe Biden, who released a report outlining the Cancer Moonshot Initiative’s (CMI) progress to date and roadmap for its four remaining years. Former Chair of ASTRO’s Board of Directors Bruce G. Haffty, M.D., FASTRO, attended on behalf of the society following months of encouragement by ASTRO for the initiative to broaden its focus and integrate radiation oncology more fully into the moonshot effort.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Agfa HealthCare recently signed on as a pilot vendor for the Radiology Society of North America's (RSNA) Image Share Validation Program, a conformity assessment program that is designed to establish standards across image-sharing vendors and at healthcare organizations.
Strategic Radiology (SR) has committed $800,000 to fund 20 Strategic Radiology Research Seed Grants through the Radiological Society of North America (RSNA) Research and Education (R&E) Foundation. SR, a consortium of 26 practice groups representing more than 1,400 radiologists from around the United States, is the second Visionaries in Practice donor to fund a named grant award via the foundation’s Inspire-Innovate-Invest: The Campaign for Funding Radiology’s Future.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
October 20, 2016 — Sectra has a complete enterprise imaging offering supporting the most image-intense departments. At ...
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Intelerad Medical Systems recently announced that Radiology Consultants of Iowa (RCI) has selected InteleOne XE as their interoperability workflow platform.
Digisonics announced the release of OB 4.8 for its OB/GYN picture archiving and communication system (PACS) and Structured Reporting System. The Digisonics system is standards-based and vendor-neutral, combining image review, structured reporting, an integrated clinical database and powerful PACS image archive into one complete solution for OB/GYN studies.
Swissray received U.S. Food and Drug Administration (FDA) approval earlier in 2016 for the ddRAura OTC digital X-ray systems, including the ddrAura OTC with Automated Positioning System (APS).
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Dicom Systems' Unifier Archive, incorporated as part of the DCMSYS ecosystem, is an archiving solution for any medical ...
October 21, 2016 — The U.S. Food and Drug Administration (FDA) issued a letter calling on radiation oncologists, medical ...
October 20, 2016 — An annual mammogram is recommended after treatment for breast cancer, but nearly one-third of women ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Earlier this year, Swissray announced U.S. Food and Drug Administration (FDA) approval for the ddRAura FMTS digital X-ray system, what the company calls an affordable and multifunctional direct digital X-ray system.
To tell or not to tell? That is the question. It has been asked — and gone unasked — for decades, tracing back to the profoundly improved resolution coming from next generation medical imaging equipment. Spurred by digital sonograms and submillimeter-resolution CTs and MRIs, physicians have questioned whether what they see is really disease. Are abnormalities benign — or are they the early signs of disease that need immediate attention?
IBA (Ion Beam Applications SA) and Philips announced in September the launch of a dedicated patient-centric Ambient Experience solution for the proton therapy gantry of IBA’s Proteus Plus proton therapy solution. The announcement makes the Philips solution now available for both Proteus One and Proteus Plus.
lifeIMAGE yesterday announced the immediate availability of lifeIMAGE 5.0, the latest upgrade to its enterprise-grade electronic medical image-sharing platform that connects thousands of hospitals across the country.
Centers that perform mammograms in the United States know their job doesn’t just stop at delivering results to the referring physician. Mammography is regulated by the government and centers need to adhere to the rules for breast cancer tracking and reporting in the Mammography Quality and Standards Act (MQSA). This means a more personal relationship with the mammography patients is necessary, as the center is responsible for providing each patient’s results and ensuring each patient has the required follow-up exams. This is a timely endeavor, and without a streamlined solution to help with breast cancer tracking and reporting, patients can get lost when waiting for priors or follow up exams causing centers to fail their annual MQSA audits. I recommend selecting a solution that will automate breast cancer tracking and reporting to improve patient care, while cutting costs and saving time. With that said, below are five changes you can make to improve breast cancer tracking and reporting within your facility.
A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment. Stereotactic radiosurgery, in combination with targeted therapy using EGFR tyrosine kinase inhibitors, resulted in the longest survival and best outcomes for patients.
RamSoft introduces Peer Review, a solution that simplifies the review process by integrating with the American College of Radiology’s (ACR) RADPEER program to improve patient care and quality assurance measures. RamSoft’s Peer Review workflow enables radiologists to review and score prior reports, helps to satisfy ACR, Joint Commission (JC) and Centers for Medicare and Medicaid Services (CMS) quality assurance accreditation requirements, and provides an unbiased review process for radiologists.
The association between provider case volume and outcomes has long been suggested in cancer care. A Yale Cancer Center team has completed a review of outcomes for patients with locally advanced squamous cell head and neck cancers treated with intensity-modulated radiation therapy (IMRT) and found a distinct association between higher-volume treatment centers and improved overall survival. The findings were presented Sept. 26 at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Boston.